All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 26, 2021
Home » Disease Forecast Reports
Email
Tweet

Disease Forecast Reports

Epidemiology analysis is essential for building a strategy in order to accurately gauge your future potential in the marketplace. Stop using black box ‘guesstimates’ and start using Disease Forecasts for a serious forecasting tool to support your epidemiology analysis and strategic planning. Each data point for every country is linked to the best single source, and forecasts are fully customizable using our exclusive calculator.

DiseaseForecasts_reportcovermock-up

Disease Forecast reports are guaranteed to:

  • Provide a 15-year forecast for G7 (U.S., Canada, France, Germany, Italy, Japan, U.K.) and BRIC (Brazil, Russia, India, China) countries
  • Include population, prevalence, segmentation, diagnosis and treatment data
  • Be created by PhD and senior epidemiologists and a leading forecast analyst

Reports are available for the following:

Anxiety disorders End stage renal disease Nonalcoholic steatohepatitis
Asthma Epilepsy Non-Hodgkin lymphoma
Atopic dermatitis Gastroesophageal reflux disease (GERD) Obesity
Atrial fibrillation Glaucoma Osteoarthritis
Bladder cancer Hepatitis B Osteoporosis
Breast cancer Hepatitis C Ovarian cancer
Cataract HIV Pancreatic cancer
Chronic back pain Hodgkin lymphoma Parkinson's disease
Chronic kidney disease Huntington's disease Prostate cancer
Chronic obstructive pulmonary disease Hypertension Psoriasis
Chronic pain Irritable bowel disease Rare diseases
Colorectal cancer Kidney cancer Rheumatoid arthritis
Congestive heart failure Leukemia Sickle cell disease
Coronary artery disease Liver cancer Spinal muscular atrophy
Crohn's disease Lung cancer Stomach cancer
Cystic fibrosis Migraine Stroke
Dementia Multiple sclerosis Ulcerative colitis
Depression Myelofibrosis
Diabetes Myocardial infarction

For the most detailed disease picture, combine Disease Forecasts with a subscription to the Incidence and Prevalence Database (IPD) – the original epidemiology database for the biopharma industry

Click here to order your Disease Forecast Report today.

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Seniors with wooden puzzle

    Cassava’s simufilam improves AD patients’ cognition, behavior

    BioWorld
    When Cassava Sciences Inc.’s president and CEO, Remi Barbier, opened up the interim analysis of the company’s open-label study for Alzheimer’s disease candidate...
  • Vaxart COVID-19 vaccine tablets

    Vaxart shares shaken despite apparently positive early data for oral COVID-19 vaccine

    BioWorld
    Vaxart Inc. investors who stuck by company shares Feb. 3 had to swallow a bitter pill – watching shares of the oral vaccine developer (NASDAQ:VXRT) fall 57.8% to...
  • IPO money

    Lucira Health launches $153M IPO

    BioWorld MedTech
    Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 25.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing